Lataa...
Minimal Residual Disease Evaluation in Childhood Acute Lymphoblastic Leukemia: An Economic Analysis
BACKGROUND: Minimal residual disease (MRD) testing by higher performance techniques such as flow cytometry and polymerase chain reaction (PCR) can be used to detect the proportion of remaining leukemic cells in bone marrow or peripheral blood during and after the first phases of chemotherapy in chil...
Tallennettuna:
| Julkaisussa: | Ont Health Technol Assess Ser |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Medical Advisory Secretariat
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4808717/ https://ncbi.nlm.nih.gov/pubmed/27099644 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|